Richard B. Bankert

5.1k total citations
138 papers, 4.1k citations indexed

About

Richard B. Bankert is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard B. Bankert has authored 138 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Immunology, 54 papers in Molecular Biology and 43 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard B. Bankert's work include Immunotherapy and Immune Responses (45 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Immune Cell Function and Interaction (30 papers). Richard B. Bankert is often cited by papers focused on Immunotherapy and Immune Responses (45 papers), Monoclonal and Polyclonal Antibodies Research (42 papers) and Immune Cell Function and Interaction (30 papers). Richard B. Bankert collaborates with scholars based in United States, Canada and Japan. Richard B. Bankert's co-authors include Nejat K. Egilmez, Raymond J. Kelleher, Sathy V. Balu‐Iyer, Michelle R. Simpson-Abelson, Elizabeth A. Repasky, Sandra J. Yokota, Edith Mathiowitz, Fang-An Chen, Lori Broderick and Hiroshi Takita and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard B. Bankert

137 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard B. Bankert United States	37	1.9k	1.6k	1.3k	614	517	138	4.1k
Patrizio Giacomini Italy	34	1.6k 0.9×	1.5k 0.9×	992 0.8×	653 1.1×	528 1.0×	134	3.6k
Philip J. Gotwals United States	28	1.1k 0.6×	1.8k 1.1×	1.1k 0.8×	244 0.4×	595 1.2×	37	4.4k
Hartwig Kosmehl Germany	38	770 0.4×	1.7k 1.1×	1.4k 1.1×	955 1.6×	587 1.1×	188	4.8k
Katherine N. Weilbaecher United States	46	1.3k 0.7×	2.5k 1.5×	3.2k 2.4×	608 1.0×	817 1.6×	124	6.1k
Maria I. Colnaghi Italy	40	1.5k 0.8×	2.1k 1.3×	1.8k 1.4×	1.8k 2.9×	526 1.0×	171	4.8k
Natarajan Muthusamy United States	40	2.0k 1.0×	2.3k 1.4×	1.3k 1.0×	431 0.7×	511 1.0×	177	5.3k
Gordon Parry United States	22	581 0.3×	1.6k 1.0×	790 0.6×	355 0.6×	337 0.7×	49	3.5k
Gerhard Moldenhauer Germany	52	2.9k 1.5×	3.4k 2.0×	2.7k 2.0×	1.8k 2.9×	860 1.7×	129	7.6k
Richard C. Bates United States	32	568 0.3×	2.2k 1.3×	1.6k 1.2×	356 0.6×	566 1.1×	51	4.3k
Silvano Ferrini Italy	55	5.5k 2.9×	2.3k 1.4×	3.0k 2.3×	889 1.4×	630 1.2×	228	8.7k

Countries citing papers authored by Richard B. Bankert

Since Specialization

Citations

This map shows the geographic impact of Richard B. Bankert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Bankert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Bankert more than expected).

Fields of papers citing papers by Richard B. Bankert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Bankert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Bankert. The network helps show where Richard B. Bankert may publish in the future.

Co-authorship network of co-authors of Richard B. Bankert

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Bankert. A scholar is included among the top collaborators of Richard B. Bankert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Bankert. Richard B. Bankert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shenoy, Gautam N., Jenni Loyall, Orla Maguire, et al.. (2018). Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses. Cancer Immunology Research. 6(2). 236–247. 60 indexed citations

Kelleher, Raymond J., Sathy V. Balu‐Iyer, Jenni Loyall, et al.. (2015). Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade. Cancer Immunology Research. 3(11). 1269–1278. 93 indexed citations

Simpson-Abelson, Michelle R., Gregory F. Sonnenberg, Hiroshi Takita, et al.. (2008). Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2Rγnull Mice. The Journal of Immunology. 180(10). 7009–7018. 73 indexed citations

Nazareth, Michael R., Lori Broderick, Michelle R. Simpson-Abelson, et al.. (2007). Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells. The Journal of Immunology. 178(9). 5552–5562. 209 indexed citations

Broderick, Lori & Richard B. Bankert. (2006). Membrane-Associated TGF-β1 Inhibits Human Memory T Cell Signaling in Malignant and Nonmalignant Inflammatory Microenvironments. The Journal of Immunology. 177(5). 3082–3088. 30 indexed citations

Broderick, Lori & Richard B. Bankert. (2006). Memory T Cells in Human Tumor and Chronic Inflammatory Microenvironments: Sleeping Beauties Re-awakened by a Cytokine Kiss. Immunological Investigations. 35(3-4). 419–436. 11 indexed citations

Broderick, Lori, Sandra J. Yokota, Joshua Reineke, et al.. (2005). Human CD4+ Effector Memory T Cells Persisting in the Microenvironment of Lung Cancer Xenografts Are Activated by Local Delivery of IL-12 to Proliferate, Produce IFN-γ, and Eradicate Tumor Cells. The Journal of Immunology. 174(2). 898–906. 58 indexed citations

Hess, Stephen D., Nejat K. Egilmez, Timothy Anderson, et al.. (2003). Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ. The Journal of Immunology. 170(1). 400–412. 57 indexed citations

Bankert, Richard B., Nejat K. Egilmez, & Stephen D. Hess. (2001). Human–SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends in Immunology. 22(7). 386–393. 72 indexed citations

10.

Bankert, Richard B., et al.. (2000). Patient Immune Response to Tumors Monitored Using Scid Mouse Models. Immunological Investigations. 29(2). 171–176. 1 indexed citations

11.

Sugano, M, Nejat K. Egilmez, Soichiro Yokota, et al.. (2000). Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.. PubMed. 60(24). 6942–9. 79 indexed citations

12.

Bumpers, Harvey L., et al.. (1996). Consistent Hepatic Metastasis of Human Colorectal Cancer in Severe Combined Immunodeficient Mice. Journal of Surgical Research. 61(1). 282–288. 1 indexed citations

13.

Sakakibara, Takashi, Fang-An Chen, Hisashi Kida, et al.. (1996). Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.. PubMed. 56(16). 3743–6. 52 indexed citations

14.

Bumpers, Harvey L., et al.. (1994). Human villous adenomas engrafted into scid mice survive for prolonged period without malignant transformation.. Journal of Clinical Investigation. 94(5). 2153–2157. 4 indexed citations

15.

Parikh, Vedant, Chiharu Nakai, Sandra J. Yokota, Richard B. Bankert, & Philip W. Tucker. (1991). COOH terminus of membrane IgM is essential for an antigen-specific induction of some but not all early activation events in mature B cells.. The Journal of Experimental Medicine. 174(5). 1103–1109. 16 indexed citations

16.

Bankert, Richard B., et al.. (1989). Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.. PubMed. 49(2). 301–8. 16 indexed citations

17.

Bankert, Richard B., et al.. (1987). Antigen-specific drug-targeting used to manipulate an immune response in vivo.. Proceedings of the National Academy of Sciences. 84(20). 7232–7236. 7 indexed citations

18.

Saji, Shigetoyo, et al.. (1984). Monoclonal Antibodies Specific for Two Different Histological Types of Human Lung Carcinoma. Hybridoma. 3(2). 119–129. 14 indexed citations

19.

Bankert, Richard B.. (1983). [15] Rapid screening and replica plating of hybridomas for the production and characterization of monoclonal antibodies. Methods in enzymology on CD-ROM/Methods in enzymology. 92. 182–195. 1 indexed citations

20.

Bankert, Richard B., et al.. (1981). Hybridomas Producing Hemolytic Plaques Used to Study the Relationship Between Monoclonal Antibody Affinity and the Efficiency of Plaque Inhibition with Increasing Concentrations of Antigen. Hybridoma. 1(1). 47–58. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact